Clinical Trial Update: A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HRS-4642 as monotherapy or in combination with Adebrelimab for advanced biliary tract tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• HRS-4642

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Biliary Tract Cancer | Phase 2 | Status: RECRUITING